Spero Therapeutics Inc (SPRO) financials · rev $66.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Spero Therapeutics Inc (SPRO) rev $66.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $66.8M | $48.0M |
| Operating Income | $6.31M | -$73.4M |
| Net Income | $8.57M | -$68.6M |
| EPS (Diluted) | $0.15 | -$1.27 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $68.9M | $110.5M |
| Current Assets | $67.3M | $107.3M |
| Cash & Equivalents | $40.3M | $52.9M |
| PP&E | N/A | N/A |
| Total Liabilities | $9.90M | $64.4M |
| Current Liabilities | $8.87M | $49.1M |
| Shareholders' Equity | $59.0M | $46.1M |
| Retained Earnings | -$451.1M | -$459.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.6M | -$23.4M |
| Financing Cash Flow | N/A | N/A |
| Net Change in Cash | -$12.6M | N/A |
FAQ
What is SPRO P/E and revenue?
Spero Therapeutics Inc (SPRO) rev $66.8M.
What is SPRO revenue?
Spero Therapeutics Inc last cached revenue is $66.8M (FY2025).
Is SPRO profitable?
Spero Therapeutics Inc last cached net income is $8.57M (FY2025).
What are SPRO total assets?
Spero Therapeutics Inc last cached total assets are $68.9M (FY2025).
What is SPRO free cash flow?
No cached cash-flow row for SPRO yet.
Not investment advice. Cached statements, not a live tape.